Daclizumab
Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody.
| Trivial name | IGHG1 |
| Catalog Number | TP-095CL |
| Alternative Name(s) | Daclizumab |
| Research Area | Transplantation |
| Molecular Formula | C6332H9808N1678O1989S42 |
| CAS# | 152923-56-3 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Daclizumab-22433.htm |
| Additional Information | Zenapax is a humanized monoclonal antibody used for prevention of renal transplant rejection |